Revolution Medicines, Inc.: capex

Value{"amount": 15990000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2025-01-01 – 2025-12-31
Statuscurrent
EntityRevolution Medicines, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-26-071563 · Open the official SEC filing →
Retrieved: 2026-08-19T16:44:57.191003+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001628171/capex/2025-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/16b687c3-c64f-412b-a2ed-a51c64ea38fa

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies